The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type

BACKGROUND & OBJECTIVES: Certain disease modifying therapies may negatively impact the humoral response to SARS-CoV-2 vaccines. Many MS related clinical, demographic, and immunological characteristics can also affect vaccine response but those have not been fully explored. This study aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakubecz, Collin, Zhang, Xiaochun Susan, Woodson, Sophia, Serra, Alessandro, Abboud, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963970/
https://www.ncbi.nlm.nih.gov/pubmed/35381535
http://dx.doi.org/10.1016/j.msard.2022.103785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963970/
https://www.ncbi.nlm.nih.gov/pubmed/35381535
http://dx.doi.org/10.1016/j.msard.2022.103785

Ejemplares similares